Skip to content

Form 3 filed by Catalio Capital Management, LP

Catalio Capital Management, LP filed this Form 3 on Iambic Therapeutics, Inc. with 0 transaction rows and 5 holding rows, accepted by EDGAR 2026-10-15 00:40:52 UTC.

Accession
0001958125-26-000010
Filed
2026-10-14
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: Iambic Therapeutics, Inc. (CIK 1997038)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Series A Convertible Preferred Stock derivativeholding I See Footnote
Series B Convertible Preferred Stock derivativeholding I See footnote
Series B-3 Convertible Preferred Stock derivativeholding I See footnote
Series B-4 Convertible Preferred Stock derivativeholding I See footnote
Convertible Promissory Notes derivativeholding I See footnote